Table 2.
CPIC guideline | Actionable result, n (%) |
---|---|
CYP2C9‐Phenytoin | 30 (30.3) |
CYP2C19‐Citalopram/Escitalopram | 43 (43.4) |
CYP2C19‐Clopidogrel | 21 (21.2) |
CYP2C19‐Sertraline | 2 (2) |
CYP2C19‐Tricyclic antidepressants | 43 (43.4) |
CYP2C19‐Voriconazole | 43 (43.4) |
CYP2C9/VKORC1‐Warfarin | 39 (39.4) |
Actionable is defined by whether a change in drug therapy may be recommended based on the genotype result.